Biotech Middle East 2017 Conference and Exhibition
Biotechnology is the biology-based technology revolutionising fields like agriculture, medicine and food, and bringing new changes every day, making it difficult to stay updated.
In recent years, the biotechnology industry has been defined by a number of mergers and acquisitions as well as several companies going public. Biotechnology draws from bio-molecular and cellular processes to formulate products ranging from drugs to industrial enzymes. The global biotechnology industry currently features over 250 products for healthcare alone. Likewise, biotechnology also increasingly finds uses in the agriculture sector to protect crops against pests and insects. The use of biotechnology in formulating new grades of bio-based fuels is currently an area witnessing considerable attention.
The global market for biotechnology is expected to reach above USD 600 billion by 2020. Increasing application scope coupled with the rising demand for effective vaccines and drugs in an attempt to improve healthcare access to patients with unmet medical needs is expected to drive market demand over the next few years. In addition, the need to enhance agricultural productivity via the use of genetically engineered seeds is expected to serve this market as a driver.
In the Middle East region, the biotechnology market is expected to grow to above US$32 billion by 2020.
The Biotech Middle East 2017 Conference and Exhibition will be held jointly to Nanotech Middle East 2017 Conference and Expo in Dubai, UAE from 4 to 6 December 2017. It sets a target to be one of the largest biotech events in Middle East, the region and worldwide. This international event will reflect the full diversity of current biotechnology science advances in research and practice that open opportunities for exploitation of knowledge, commercially or otherwise, together with news, discussion and comment on broader issues of general interest and concern.